Assessment of Lassa fever sample and case management preparedness in Nigeria
2017: challenges and way forward
Fatima Saleh1,&, Chioma Dan-Nwafor2,3, Mary Doshima2, Kayode Fasominu4, Assad Hassan1, Elsie Ilori2, Emmanuel Agogo2, Olubunmi Ojo2, Patrick Nguku1, Favour Makava4, Chikwe Ihekweazu2
1Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria, 2Nigeria Centre for Disease Control, Abuja, Nigeria, 3African Field Epidemiology Network, Nigeria, 4University of Maryland Baltimore, Nigeria
Fatima Saleh, Nigeria Field Epidemiology and Laboratory Training Programme, Asokoro, Abuja, Nigeria
Lassa fever remains an important cause of morbidity and mortality in West
Africa. In Nigeria, Lassa fever (LF) is endemic with an annual cycle of incident
cases across the country. Despite seasonal epidemic preparedness and response
efforts, there is still evidence of low clinical index of suspicion, poor sample
management and delay in treatment resulting in nosocomial transmission, long
turnaround time (TAT) for laboratory diagnosis and high case-fatality-rates
a structured questionnaire on sample and case management preparedness was developed by the multi-sectoral National Lassa Fever Working Group. The questionnaires were administered via telephone calls to all the 37 State epidemiologists. Variables of interest were summarized in frequencies, means and proportions using Epi-info Version 7.
most the states, 36 (97%) collect Lassa fever samples within 24 hours with 31 (83.7%) transporting samples immediately using personal delivery as mode of transportation. Majority (78%), of states routinely use standard triple packaging and 24 (64%) preserve samples in cold box prior to transportation. Two laboratories are designated for testing of viral hemorrhagic fevers in Nigeria (University of Lagos Teaching Hospital (LUTH) and Irrua Specialist Teaching Hospital (ISTH). The median laboratory TAT for LUTH is 48 hours (range 24 - 120) while for ISTH is 48 hours (range 24 - 48). Only sixteen states (43%) have designated Viral Hemorrhagic Fever (VHF) treatment centers with isolation units. Twenty-six states (70%) have trained personnel and a similar proportion (69%) commence presumptive treatment before receipt of laboratory result. Only 3 (8%) States have ribavirin stock-out while 2 (5%) States have short dated Ribavirin stock.
there are nationwide gaps in sample and case management preparedness for Lassa fever outbreaks in Nigeria. Therefore the need for the establishment of designated functional VHF treatment centers in all states, active management of Ribavirin stocks and improvement in laboratory turn-around time.
Nigeria CDC/Nigeria Field Epidemiology and Laboratory Training Programme 2<sup>nd</sup> Annual Scientific Conference (Abuja)
To create a platform for epidemiologists and public health physicians to share their scientific works, NCDC/NFELTP organized the 2nd annual scientific conference with the theme "strengthening one health through field epidemiology training" at Transcorp Hilton Hotel, Abuja, Nigeria from July 5-7, 2017. The objectives of the conference were to provide residents and graduates a forum to share findings from their field activities; provide training opportunity for trainees on scientific communication; provide an opportunity for epidemiological networking as well as create a forum to discuss pertinent public health issues. In attendance were dignitaries from the United States Centers for Disease Control and Prevention (CDC), USAID, WHO, Africa CDC, Ministries Departments and Agencies, University officials and other implementing partners. With the current rise in zoonotic diseases, the conference also featured a two-day pre-conference workshop on One Health which prioritized zoonotic infectious diseases in Nigeria using standardized prioritization methods. A second workshop focused on antimicrobial resistance. There were 38 oral presentations, 60 poster presentations and 2 plenary sessions. The presentations covered various sub-themes ranging from outbreak investigations, case management, health system strengthening, vaccine preventable diseases, communicable diseases and surveillance. The conference featured a National Night and climaxed with awards to outstanding presenters.
Dates: 05 Jul 17 - 07 Jul 17
Venue: Transcorp Hilton Hotel
Organizers: Nigeria Centre for Disease Control / Nigeria Field Epidemiology and Laboratory Training Programme
Contact person: Dr Patrick Nguku (firstname.lastname@example.org)